S100鈣結(jié)合蛋白A8(S100A8)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法)
ELISA Kit for S100 Calcium Binding Protein A8 (S100A8)
MRP8; MIF; 60B8AG; CAGA; CFAG; CGLA; CP-10; L1Ag; NIF; P8; Calgranulin A; Cystic fibrosis antigen; Leukocyte L1 complex light chain; Migration inhibitory factor-related protein 8
- 編號SEB792Mu
 - 物種Mus musculus (Mouse,小鼠)相同的名稱,不同的物種。
 - 實(shí)驗(yàn)方法雙抗夾心
 - 反應(yīng)時長3h
 - 檢測范圍7.8-500pg/mL
 - 靈敏度最小可檢測劑量小于等于3.3pg/mL.
 - 樣本類型serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
 - 下載英文說明書 中文說明書
 - 規(guī)格48T96T96T*596T*1096T*100
 - 價格¥ 2873¥ 4104¥ 18468¥ 34884¥ 287280
 - 欲了解實(shí)際交易價格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
 
特異性
                        本試劑盒用于檢測S100鈣結(jié)合蛋白A8(S100A8),經(jīng)檢測與其它相似物質(zhì)無明顯交叉反應(yīng)。
                        由于受到技術(shù)及樣本來源的限制,不可能完成對所有相關(guān)或相似物質(zhì)交叉反應(yīng)檢測,因此本試劑盒有可能與未經(jīng)檢測的其它物質(zhì)有交叉反應(yīng)。
                    
回收率
分別于定值血清及血漿樣本中加入一定量的S100鈣結(jié)合蛋白A8(S100A8)(加標(biāo)樣品),重復(fù)測定并計算其均值,回收率為測定值與理論值的比率。
| 樣本 | 回收率范圍(%) | 平均回收率(%) | 
| serum(n=5) | 97-105 | 101 | 
| EDTA plasma(n=5) | 78-98 | 95 | 
| heparin plasma(n=5) | 91-99 | 94 | 
精密度
                    精密度用樣品測定值的變異系數(shù)CV表示。CV(%) = SD/mean×100 
                    批內(nèi)差:取同批次試劑盒對低、中、高值定值樣本進(jìn)行定量檢測,每份樣本連續(xù)測定20 次,分別計算不同濃度樣本的平均值及SD值。
                    批間差:選取3個不同批次的試劑盒分別對低、中、高值定值樣本進(jìn)行定量測定,每個樣本使用同一試劑盒重復(fù)測定8次,分別計算不同濃度樣本的平均值及SD值。
                    批內(nèi)差: CV<10% 
                    批間差: CV<12% 
線性
在定值血清及血漿樣本內(nèi)加入適量的S100鈣結(jié)合蛋白A8(S100A8),并倍比稀釋成1:2,1:4,1:8,1:16的待測樣本,線性范圍即為稀釋后樣本中S100鈣結(jié)合蛋白A8(S100A8)含量的測定值與理論值的比率。
| 樣本 | 1:2 | 1:4 | 1:8 | 1:16 | 
| serum(n=5) | 91-101% | 83-93% | 89-97% | 98-105% | 
| EDTA plasma(n=5) | 79-98% | 78-101% | 94-101% | 79-101% | 
| heparin plasma(n=5) | 89-101% | 97-104% | 83-99% | 79-98% | 
穩(wěn)定性
                    經(jīng)測定,試劑盒在有效期內(nèi)按推薦溫度保存,其活性降低率小于5%。
                    為減小外部因素對試劑盒破壞前后檢測值的影響,實(shí)驗(yàn)室的環(huán)境條件需盡量保持一致,尤其是實(shí)驗(yàn)室內(nèi)溫度、濕度及溫育條件。其次由同一實(shí)驗(yàn)員來進(jìn)行操作可減少人為誤差。
                
實(shí)驗(yàn)流程
1. 實(shí)驗(yàn)前標(biāo)準(zhǔn)品、試劑及樣本的準(zhǔn)備;
                            2. 加樣(標(biāo)準(zhǔn)品及樣本)100µL,37°C孵育1小時;
                            3. 吸棄,加檢測溶液A100µL,37°C孵育1小時;
                            4. 洗板3次;
                            5. 加檢測溶液B100µL,37°C孵育30分鐘;
                            6. 洗板5次;
                            7. 加TMB底物90µL,37°C孵育10-20分鐘;
                            8. 加終止液50µL,立即450nm讀數(shù)。
實(shí)驗(yàn)原理
將S100鈣結(jié)合蛋白A8(S100A8)抗體包被于96孔微孔板中,制成固相載體,向微孔中分別加入標(biāo)準(zhǔn)品或標(biāo)本,其中的S100鈣結(jié)合蛋白A8(S100A8)與連接于固相載體上的抗體結(jié)合,然后加入生物素化的S100鈣結(jié)合蛋白A8(S100A8)抗體,將未結(jié)合的生物素化抗體洗凈后,加入HRP標(biāo)記的親和素,再次徹底洗滌后加入TMB底物顯色。TMB在過氧化物酶的催化下轉(zhuǎn)化成藍(lán)色,并在酸的作用下轉(zhuǎn)化成最終的黃色。顏色的深淺和樣品中的S100鈣結(jié)合蛋白A8(S100A8)呈正相關(guān)。用酶標(biāo)儀在450nm波長下測定吸光度(O.D.值),計算樣品濃度。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種:Mus musculus (Mouse,小鼠) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) | 
| RPB792Mu02 | S100鈣結(jié)合蛋白A8(S100A8)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| EPB792Mu61 | S100鈣結(jié)合蛋白A8(S100A8)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| APB792Mu61 | S100鈣結(jié)合蛋白A8(S100A8)活性蛋白 | Cell?culture;?Activity?Assays. | 
| RPB792Mu01 | S100鈣結(jié)合蛋白A8(S100A8)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| PAB792Mu01 | S100鈣結(jié)合蛋白A8(S100A8)多克隆抗體 | WB; IHC | 
| PAB792Mu02 | S100鈣結(jié)合蛋白A8(S100A8)多克隆抗體 | WB; IHC; ICC; IP. | 
| LAB792Mu81 | S100鈣結(jié)合蛋白A8(S100A8)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. | 
| LAB792Mu71 | S100鈣結(jié)合蛋白A8(S100A8)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. | 
| MAB792Mu21 | S100鈣結(jié)合蛋白A8(S100A8)單克隆抗體 | WB; IHC; ICC; IP. | 
| SEB792Mu | S100鈣結(jié)合蛋白A8(S100A8)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| LMB792Mu | S100鈣結(jié)合蛋白A8(S100A8)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. | 
| KSB792Mu01 | S100鈣結(jié)合蛋白A8(S100A8)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | Main materials for "Do It (ELISA Kit) Yourself". | 
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) | 
| Biochemical and Biophysical Research Communications | High circulating levels of S100A8/A9 complex (calprotectin) in male Japanese with abdominal adiposity and dysregulated expression of S100A8 and S100A9 in adipose tissues of obese mice[ScienceDirect: S0006291X1200352X] | 
| American Journal of Reproductive Immunology | Association of Increased S100A8 Serum Protein with Early Pregnancy Loss[Pubmed:25252120] | 
| the faseb journal | Soluble receptor for advanced glycation end products inhibits disease progression in autosomal dominant polycystic kidney disease by down-regulating cell proliferation[PubMed: 25934702] | 
| J Immunol | S100A8 Production in CXCR2-Expressing CD11b+ Gr-1high Cells Aggravates Hepatitis in Mice Fed a High-Fat and High-Cholesterol Diet[PubMed: 26608915] | 
| PLoS?One | Analytical Performance of ELISA Assays in Urine: One More Bottleneck towards Biomarker Validation and Clinical Implementation[Pubmed:26889680] | 
| Journal?of?Alzheimer's?Disease | Proteomics?Analysis?of?Blood?Serums?from?Alzheimer's?Disease?Patients?Using?iTRAQ?LabelingTechnology.[pubmed:27911324] | 
| ?Journal of Functional Foods | Standardized ethanolic extract of the rhizome of Curcuma xanthorrhiza prevents murine ulcerative colitis by regulation of inflammation[S1756464617300208] | 
| International?Journal?of?Molecular?Medicine | Proinflammatory effects of S100A8/A9 via TLR4 and RAGE signaling pathways in BV-2 microglial cells[pubmed:28498464] | 
| International journal of molecular sciences | Immune Modulating Topical S100A8/A9 Inhibits Growth of Pseudomonas aeruginosa and Mitigates Biofilm Infection in Chronic Wounds.[pubmed:28672877] | 
| Gastroenterology | Tu1938-Micronutrients Assessment in Patients with Cirrhosis[10.1016:S0016-5085(18)33544-3] | 
| Gastroenterology | Tu1942-PI3K/AKT-Mediated Upregulation of C7 Inhibits Colorectal Cancer Proliferation and Metastasis[10.1016:S0016-5085(18)33544-5] | 
| Journal of Biological Chemistry | Signaling between pancreatic β-cells and macrophages via S100 calcium-binding protein A8 exacerbates β-cell apoptosis and islet inflammation[Pubmed:29496993] | 
| European?review for?medical?and pharmacological?sciences | S100A8/A9 promotes MMP-9 expression in the fibroblasts from cardiac rupture after myocardial infarction by inducing macrophages secreting TNFα.[Pubmed:29949169] | 
| Foodborne Pathogens and Disease | Synergistic effect of immunomodulatory S100A8/A9 and ciprofloxacin against Pseudomonas aeruginosa biofilm in a murine chronic wound model[Pubmed: 31116394] | 
| Kidney International Reports | Systemic Inflammation Precedes Microalbuminuria in Diabetes[] | 
| Cancer Management and Research | iTRAQ-based quantitative protein expression profiling of biomarkers in childhood B-cell and T-cell acute lymphoblastic leukemia[Pubmed: 31440093] | 
| scandinavian journal of clinical & laboratory investigation | Serum S100A6, S100A8, S100A9 and S100A11 proteins in colorectal neoplasia: results of a single centre prospective study[Pubmed: 31856598] | 
| ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE | Analysis of novel serum markers of fibrosis and angiogenesis in patients with alcoholic liver cirrhosis[] | 
| MOLECULAR VISION | Quantification of a panel for dry-eye protein biomarkers in tears: A comparative pilot study using standard ELISA and customized microarrays[34012227] | 
| university of copenhagen | Adjunctive S100A8/A9 Immunomodulation Hinders Cipro fl oxacin Resistance in[] | 





